These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr. Polák J; Koza V; Cetkovský P; Haskovec C Bone Marrow Transplant; 2000 May; 25(10):1109-10. PubMed ID: 10828875 [No Abstract] [Full Text] [Related]
6. [Chronic myelocytic leukemia associated with cytomegalovirus induced sialoadenitis after unrelated allogeneic bone marrow transplantation]. Yoshida M; Ueda S; Harano H; Yamazaki E; Kato K; Tanabe J; Okamoto R; Ogawa K; Mohri H; Okubo T; Sasaki S; Matsuzaki M; Nakatani Y; Chiba N Rinsho Ketsueki; 1996 Jan; 37(1):46-52. PubMed ID: 8683867 [TBL] [Abstract][Full Text] [Related]
7. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795 [TBL] [Abstract][Full Text] [Related]
8. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients. Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904 [TBL] [Abstract][Full Text] [Related]
9. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features. Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800 [TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha in the treatment of chronic myeloid leukemia]. Guilhot F Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394 [No Abstract] [Full Text] [Related]
11. Autotransplantation for chronic myeloid leukemia: is it useful? Olavarria E Haematologica; 2002 Jan; 87(1):3-6. PubMed ID: 11801458 [No Abstract] [Full Text] [Related]
13. Current treatment of chronic myelogenous leukemia. Goldman JM Pathol Biol (Paris); 1989 Feb; 37(2):128-9. PubMed ID: 2469054 [No Abstract] [Full Text] [Related]
14. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia. Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699 [No Abstract] [Full Text] [Related]
15. [Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia]. Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Senatore M Haematologica; 1990; 75 Suppl 4():33-40. PubMed ID: 1705912 [No Abstract] [Full Text] [Related]
16. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group. Simonsson B; Oberg G; Killander A; Björeman M; Björkholm M; Gahrton G; Stenke L; Turesson I; Udén AM; Malm C Bone Marrow Transplant; 1994; 14 Suppl 3():S55-6. PubMed ID: 7535154 [No Abstract] [Full Text] [Related]
17. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278 [TBL] [Abstract][Full Text] [Related]